Switch to:
GuruFocus has detected 1 Warning Sign with Repros Therapeutics Inc \$RPRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Repros Therapeutics Inc (NAS:RPRX)
EV-to-Revenue
394.68 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Repros Therapeutics Inc's enterprise value is \$19.73 Mil. Repros Therapeutics Inc's revenue for the trailing twelve months (TTM) ended in Sep. 2016 was \$0.05 Mil. Therefore, Repros Therapeutics Inc's EV/Revenue ratio for today is 394.68.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Repros Therapeutics Inc's stock price is \$1.19. Repros Therapeutics Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2016 was \$0.00. Therefore, Repros Therapeutics Inc's P/S Ratio for today is 595.00.

Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Repros Therapeutics Inc's EV/Revenue for today is calculated as:

 EV/Revenue = Enterprise Value (Today) / Revenue (TTM) = 19.734 / 0.05 = 394.68

Repros Therapeutics Inc's current Enterprise Value is \$19.73 Mil.
Repros Therapeutics Inc's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 was 0.008 (Dec. 2015 ) + 0.017 (Mar. 2016 ) + 0.015 (Jun. 2016 ) + 0.01 (Sep. 2016 ) = \$0.05 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Repros Therapeutics Inc's P/S Ratio for today is calculated as:

 P/S Ratio = Share Price (Today) / Revenue Per Share (TTM) = 1.19 / 0.002 = 595.00

Repros Therapeutics Inc's share price for today is \$1.19.
Repros Therapeutics Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was 0 (Dec. 2015 ) + 0.001 (Mar. 2016 ) + 0.001 (Jun. 2016 ) + 0 (Sep. 2016 ) = \$0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Repros Therapeutics Inc Annual Data

 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 ev2rev 203.66 61.68 520.50 33.51 57.46 27,505.10 82,019.33 43,159.50 24,431.45 730.38

Repros Therapeutics Inc Quarterly Data

 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 ev2rev 33,915.00 20,501.78 24,431.45 24,384.31 23,575.33 30,901.52 730.38 279.42 649.88 840.33
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)